Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-26 @ 10:34 AM
NCT ID:
NCT00623428
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \>=18 years of age;
* serological evidence of chronic hepatitis C (CHC);
* CHC genotype 2 or 3;
* receiving PEGASYS + Copegus according to local standard of care and no rapid viral response (RVR);
* compensated liver disease.
Exclusion Criteria:
* pegylated interferon, standard interferon or ribavirin therapy at any time prior to initiation of current therapy with PEGASYS + Copegus;
* coinfection with hepatitis A or B, or human immunodeficiency virus (HIV);
* history or other evidence of decompensated liver disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00623428
Study Brief:
Protocol Section:
NCT00623428